Psoriasis is a chronic immune-driven skin condition that causes thick, scaly patches to build up on the skin’s surface. It affects roughly 125 million people worldwide, about 2 to 3 percent of the global population, with more than 8 million of those in the United States alone. The condition isn’t contagious, and it isn’t simply a skin problem. It’s rooted in an immune system malfunction that speeds up skin cell production and drives inflammation throughout the body.
How Psoriasis Works Inside the Body
Normal skin cells take about 26 to 27 days to grow, rise to the surface, and shed. In psoriasis, the immune system sends faulty signals that compress this cycle dramatically, pushing new cells to the surface far faster than old ones can fall away. The result is a pileup of skin cells that forms the raised, silvery-white patches most people associate with the condition.
The engine behind this is a specific chain reaction in the immune system. A signaling molecule called IL-23 activates a group of immune cells known as Th17 cells. Once switched on, these cells release another signal, IL-17, which binds directly to skin cells and stimulates them to multiply. IL-17 also triggers the release of inflammatory chemicals that recruit even more immune cells to the area, creating a self-reinforcing loop: inflammation drives skin cell growth, which draws more inflammation. This is why psoriasis tends to persist and flare rather than simply appear once and resolve.
Genetics and Family History
Psoriasis has a strong genetic component. The most well-established genetic link involves a marker called HLA-Cw6, located on chromosome 6. This association has been confirmed across multiple racial and ethnic groups and is considered one of the major genetic determinants of the disease. Researchers believe one or more genes clustered in this region of the genome help govern how the immune system interacts with skin cells.
Having a parent or sibling with psoriasis significantly increases your risk, though it doesn’t guarantee you’ll develop it. Many people carry the genetic predisposition without ever having a flare, which is why environmental triggers play such an important role in tipping the balance.
Common Triggers That Start or Worsen Flares
Psoriasis often appears or worsens after a specific trigger, even in people who’ve gone months or years without symptoms. Strep throat is one of the most well-documented triggers, particularly for a form called guttate psoriasis in children and young adults. Stress, heavy alcohol use, smoking, and certain medications can also provoke flares.
Physical injury to the skin is another notable trigger. This is called the Koebner phenomenon: new psoriasis patches develop at the exact site of a cut, scrape, sunburn, tattoo, insect bite, or even a surgical incision. These new lesions typically appear within 10 to 20 days of the injury, run in a straight line along the wound, and look identical to existing psoriasis patches. Any damage that penetrates both the outer and middle layers of skin can set it off.
Types of Psoriasis and How They Look
Not all psoriasis looks the same. There are several distinct types, and knowing which one you’re dealing with matters because they affect different parts of the body and respond to different treatments.
- Plaque psoriasis is by far the most common form. It causes dry, raised patches covered in silvery scales, typically on the elbows, knees, lower back, and scalp. Patches can range from a few small spots to large areas of coverage.
- Guttate psoriasis appears as small, drop-shaped spots scattered across the trunk, arms, or legs. It primarily affects children and young adults and is often triggered by a strep throat infection.
- Inverse psoriasis develops in skin folds, including the groin, buttocks, and under the breasts. Instead of thick scales, it causes smooth, inflamed patches that worsen with friction and sweating. It’s sometimes mistaken for a fungal or bacterial skin infection.
- Pustular psoriasis is rare and looks quite different from other forms. It produces clearly defined blisters filled with pus, either in widespread patches or concentrated on the palms and soles.
How Psoriasis Is Identified
Psoriasis is usually diagnosed based on its appearance, without the need for blood tests or biopsies. A dermatologist can typically distinguish it from conditions that look similar. Eczema, the most common lookalike, tends to affect the inner creases of elbows and knees (flexor surfaces), while plaque psoriasis favors the outer surfaces (extensor surfaces). Eczema also lacks the characteristic silvery scale.
Inverse psoriasis can be confused with fungal infections because of its location in skin folds. Pustular psoriasis may resemble severe bacterial skin infections. In ambiguous cases, a small skin biopsy can confirm the diagnosis by revealing the distinctive pattern of rapid skin cell turnover and immune cell infiltration.
Beyond the Skin: Related Health Risks
Because psoriasis is fundamentally an immune system disorder, its effects aren’t limited to the skin. The same inflammatory process that drives skin cell buildup can affect joints, blood vessels, the heart, and other organs. Roughly 30 percent of people with psoriasis develop psoriatic arthritis, a condition that causes joint pain, stiffness, and swelling. In most cases, skin symptoms appear first, with joint involvement following within a decade, though the reverse can happen.
People with psoriasis also face higher rates of cardiovascular disease, type 2 diabetes, and metabolic syndrome. The chronic, system-wide inflammation appears to damage blood vessels and disrupt metabolic function over time. This is why managing psoriasis is about more than clearing skin patches. Controlling inflammation has implications for long-term health well beyond what’s visible on the surface.
How Psoriasis Is Managed
There is no cure for psoriasis, but treatments can effectively control symptoms and reduce flares. The approach depends largely on severity.
For mild cases, topical treatments applied directly to the skin are the first step. Prescription-strength corticosteroid creams are the most commonly used option, working by calming local inflammation and slowing skin cell growth. These are effective for small, isolated patches on most body areas.
Moderate to severe psoriasis often requires more aggressive strategies. Phototherapy, which involves controlled exposure to specific wavelengths of ultraviolet light, is effective for both plaque and guttate psoriasis. It works by slowing down the overactive skin cell production. Sessions are typically done in a dermatologist’s office two to three times per week.
When psoriasis covers larger areas or doesn’t respond to topical treatments and light therapy, systemic medications that work throughout the body become necessary. Older options include oral medications that broadly suppress immune activity. Newer biologic therapies are more targeted, blocking the specific immune signals (like IL-17 and IL-23) that drive the disease. These biologics have transformed treatment for severe psoriasis because they interrupt the exact inflammatory loop responsible for the condition, often producing dramatic clearing with fewer side effects than older systemic drugs.
Most people with psoriasis cycle through periods of flaring and remission throughout their lives. Identifying and avoiding personal triggers, maintaining consistent treatment, and monitoring for joint symptoms or other complications are the practical pillars of living with the condition long term.